CSPC Pharmaceutical logo

1093 - CSPC Pharmaceutical Share Price

HK$17.68 -0.1  -0.3%

Last Trade - 5:55am

Sector
Healthcare
Size
Large Cap
Market Cap £10.79bn
Enterprise Value £10.40bn
Revenue £2.31bn
Position in Universe 110th / 5943
Bullish
Bearish
Unlock 1093 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

1093 Revenue Unlock 1093 Revenue

Net Income

1093 Net Income Unlock 1093 Revenue

Normalised EPS

1093 Normalised EPS Unlock 1093 Revenue

PE Ratio Range

1093 PE Ratio Range Unlock 1093 Revenue

Dividend Yield Range

1093 Dividend Yield Range Unlock 1093 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
1093 EPS Forecasts Unlock 1093 Revenue
Profile Summary

CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated June 16, 1992
Public Since June 21, 1994
No. of Shareholders: n/a
No. of Employees: 18,039
Sector Healthcare
Industry Pharmaceuticals
Index Hang Seng Composite , Hang Seng , Hang Seng Composite LargeCap & MidCap , Hang Seng Mainland 100 , Hang Seng Composite Mid & SmallCap ,
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 6,236,338,403
Free Float (0.0%)
Eligible for
ISAs
SIPPs
1093 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 1093
Upcoming Events for 1093
Monday 16th March, 2020 Estimate
Full Year 2019 CSPC Pharmaceutical Group Ltd Earnings Release
Tuesday 19th May, 2020 Estimate
Q1 2020 CSPC Pharmaceutical Group Ltd Earnings Release
Tuesday 26th May, 2020 Estimate
CSPC Pharmaceutical Group Ltd Annual Shareholders Meeting
Similar to 1093
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.